Trial Details
COMPLETEDBasic Information
| Clinical ID | c3429 |
|---|---|
| Identifier | NCT02077699 |
| Trial Title | Efficacy Evaluation of a Commercial Preparation Containing Lactobacillus Casei DG on the Reduction of the Painful Symptoms Related to the Irritable Bowel Syndrome (IBS). A Pilot Clinical Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DIETARY_SUPPLEMENT: Lactobacillus casei DG |
Participant Information
| Sponsor | SOFAR S.p.A. |
|---|---|
| City | Roma |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2012-03 |
|---|---|
| Primary Completion Date | 2014-06 |
| Completion Date | 2014-06 |